Indivior reshuffles board as CFO exits under Oaktree pressure

Reuters12-17 15:56

UPDATE 1-Indivior reshuffles board as CFO exits under Oaktree pressure

Adds background in paragraph 2, 5, Oaktree director quote in paragraph 4

Dec 17 (Reuters) - Indivior INDV.L said on Tuesday its finance chief Ryan Preblick will step down as the British drugmaker makes changes to its board following pressure from No. 2 shareholder Oaktree Capital.

The maker of opioid addiction treatment Sublocade has been engaged in conversations with Oaktree Capital Management following the investment fund's repeated calls for the drugmaker to refresh its board and take strategic actions to recover its falling market share.

Indivior also appointed Robert Schriesheim and Joe Ciaffoni as independent non-executive directors, and said it has agreed to move towards a more standard U.S. system of remuneration for directors following its recent primary listing in New York.

"We believe the constructive actions Indivior's Board has undertaken, together with the appointment of these new independent directors, will accelerate the Company's operational execution and enhance long-term shareholder value," said Andrew West, Managing Director in Oaktree's Value Opportunities Group.

In October, the company had issued its second profit and revenue warning in the span of three months after sales for Sublocade remained weak against Swedish pharmaceutical firm Camurus' CAMX.ST competing drug Brixadi.

(Reporting by Yadarisa Shabong in Bengaluru and Yamini Kalia; Editing by Sherry Jacob-Phillips and Mrigank Dhaniwala)

((Yadarisa.Shabong@thomsonreuters.com; +91 9742735150;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492298254?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-17 15:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492298254","market":"us","top_or_hot":-1,"title":"Indivior reshuffles board as CFO exits under Oaktree pressure","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>UPDATE 1-Indivior reshuffles board as CFO exits under Oaktree pressure</title></head><body><p>Adds background in paragraph 2, 5, Oaktree director quote in paragraph 4</p><p>\n<span>Dec 17 (Reuters)</span><span> - </span>Indivior <span>INDV.L</span> said on Tuesday its finance chief Ryan Preblick will step down as the British drugmaker makes changes to its board following pressure from No. 2 shareholder Oaktree Capital.</p><p>The maker of opioid addiction treatment Sublocade has been engaged in conversations with Oaktree Capital Management following the investment fund's <span>repeated calls</span> for the drugmaker to refresh its board and take strategic actions to recover its falling market share.</p><p>Indivior also appointed Robert Schriesheim and Joe Ciaffoni as independent non-executive directors, and said it has agreed to move towards a more standard U.S. system of remuneration for directors following its recent primary listing in New York. </p><p>\"We believe the constructive actions Indivior's Board has undertaken, together with the appointment of these new independent directors, will accelerate the Company's operational execution and enhance long-term shareholder value,\" said Andrew West, Managing Director in Oaktree's Value Opportunities Group.</p><p>In October, the company had issued its <span>second profit and revenue warning</span> in the span of three months after sales for Sublocade remained weak against Swedish pharmaceutical firm Camurus' <span>CAMX.ST</span> competing drug Brixadi.</p><p> (Reporting by Yadarisa Shabong in Bengaluru and Yamini Kalia; Editing by Sherry Jacob-Phillips and Mrigank Dhaniwala)</p><p> ((Yadarisa.Shabong@thomsonreuters.com; +91 9742735150;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Indivior reshuffles board as CFO exits under Oaktree pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIndivior reshuffles board as CFO exits under Oaktree pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 15:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4N3NI0I0:2><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>UPDATE 1-Indivior reshuffles board as CFO exits under Oaktree pressureAdds background in paragraph 2, 5, Oaktree director quote in paragraph 4\nDec 17 (Reuters) - Indivior INDV.L said on Tuesday its ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4N3NI0I0:2\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BN","symbol_name":"Brookfield","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4N3NI0I0:2","article_id":"2492298254","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492298254","pubTimestamp":1734422174,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"UPDATE 1-Indivior reshuffles board as CFO exits under Oaktree pressureAdds background in paragraph 2, 5, Oaktree director quote in paragraph 4. Dec 17  - Indivior INDV.L said on Tuesday its finance chief Ryan Preblick will step down as the British drugmaker makes changes to its board following pressure from No. 2 shareholder Oaktree Capital.The maker of opioid addiction treatment Sublocade has been engaged in conversations with Oaktree Capital Management following the investment fund's repeated calls for the drugmaker to refresh its board and take strategic actions to recover its falling market share.Indivior also appointed Robert Schriesheim and Joe Ciaffoni as independent non-executive directors, and said it has agreed to move towards a more standard U.S. system of remuneration for directors following its recent primary listing in New York. \"We believe the constructive actions Indivior's Board has undertaken, together with the appointment of these new independent directors, will acce","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BN":"Brookfield","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","BK4585":"ETF&股票定投概念","INDV.UK":"INDIVIOR","BK4588":"碎股","BK4135":"资产管理与托管银行","BK5011":"制药"},"translate_title":"首席财务官在橡树资本压力下退出，Indivior改组董事会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BN":0.9,"INDV.UK":0.9},"content_text":"UPDATE 1-Indivior reshuffles board as CFO exits under Oaktree pressureAdds background in paragraph 2, 5, Oaktree director quote in paragraph 4\nDec 17 (Reuters) - Indivior INDV.L said on Tuesday its finance chief Ryan Preblick will step down as the British drugmaker makes changes to its board following pressure from No. 2 shareholder Oaktree Capital.The maker of opioid addiction treatment Sublocade has been engaged in conversations with Oaktree Capital Management following the investment fund's repeated calls for the drugmaker to refresh its board and take strategic actions to recover its falling market share.Indivior also appointed Robert Schriesheim and Joe Ciaffoni as independent non-executive directors, and said it has agreed to move towards a more standard U.S. system of remuneration for directors following its recent primary listing in New York. \"We believe the constructive actions Indivior's Board has undertaken, together with the appointment of these new independent directors, will accelerate the Company's operational execution and enhance long-term shareholder value,\" said Andrew West, Managing Director in Oaktree's Value Opportunities Group.In October, the company had issued its second profit and revenue warning in the span of three months after sales for Sublocade remained weak against Swedish pharmaceutical firm Camurus' CAMX.ST competing drug Brixadi. (Reporting by Yadarisa Shabong in Bengaluru and Yamini Kalia; Editing by Sherry Jacob-Phillips and Mrigank Dhaniwala) ((Yadarisa.Shabong@thomsonreuters.com; +91 9742735150;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive,event","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492298254"}